[{"country": "United States", "city": "Santa Clarita", "address_1": "21100 Centre Pointe Pkwy", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Products contain undeclared active pharmaceutical ingredients; desmethyl carbondenafil and dapoxetine.", "address_2": "", "product_quantity": "868 Bottles", "code_info": "All Lots", "center_classification_date": "20160216", "distribution_pattern": "Nationwide", "state": "CA", "product_description": "Rhino 7 3000, 6 count bottles, Distributed by Rhino 7, Made in USA.", "report_date": "20160224", "classification": "Class I", "openfda": {}, "recalling_firm": "MSNV, Inc dba National Video Supply", "recall_number": "D-0670-2016", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "72512", "termination_date": "20170601", "more_code_info": "", "recall_initiation_date": "20151001", "postal_code": "91350-2978", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["REGENER-EYES"], "generic_name": ["GLYCERIN"], "manufacturer_name": ["Regenerative Processing Plant, LLC"], "product_ndc": ["82305-006"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["GLYCERIN"], "rxcui": ["2610311", "2610313"], "spl_id": ["30caa73a-ed9b-753f-e063-6394a90add63"], "spl_set_id": ["e7796d0d-13d7-73c3-e053-2995a90a8bde"], "package_ndc": ["82305-006-01", "82305-006-02"], "is_original_packager": [true], "nui": ["N0000185370", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0009417"], "pharm_class_epc": ["Non-Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_cs": ["Allergens [CS]", "Glycerol [CS]"], "unii": ["PDC6A3C0OX"]}, "product_type": "Drugs", "event_id": "95912", "recalling_firm": "Regenerative Processing Plant, LLC", "address_1": "34176 Us Highway 19 N", "address_2": "", "postal_code": "34684-2144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0152-2025", "product_description": "LITE Regener-Eyes, Ophthalmic Solution (glycerin 0.4%), 3mL bottles, Distributed by: Regener-Eyes, Tampa, FL; Manufactured by: Regenerative Processing Plant, LLC, 34176 US HWY 19N, FL, NDC 82305-006-01", "product_quantity": "170812 bottles", "reason_for_recall": "Lack of Sterility Assurance", "recall_initiation_date": "20241210", "center_classification_date": "20241217", "termination_date": "20250627", "report_date": "20241225", "code_info": "Lot #:  P121322A, P121322B, Exp. Date 12/13/2024; P121422A, Exp. Date 12/14/2024; P121922A, P121922B, Exp. Date 12/19/2024; P122022A, Exp. Date 12/20/2024; P122122A, P122122B, Exp. Date 12/21/2024; P122622A, P122622B, Exp. Date 12/26/2024; P122722A, P122722B, Exp. Date 12/27/2024; P122822A, P122822B, Exp. Date 12/28/2024. P010223A, Exp. Date 1/2/2025; P010323LV1, Exp. Date 1/3/2025; P010523A, P010523B, Exp. Date 1/5/2025; P010923A, Exp. Date 1/9/2025; P011023LV2, Exp. Date 1/10/2025, P011223A, P011223B, Exp. Date 1/12/2025; P011623A; Exp. Date 1/16/2025, P011723LV3, Exp. Date 1/17/2025; P011923A, P011923B, Exp. Date 1/19/2025; P012323A, P012323B, Exp. Date 1/23/2025; P012523A, Exp. Date 1/25/2025; P013123A, Exp. Date 1/31/2025; P020223A, Exp. Date 2/2/2025; P020623A, Exp. Date 2/6/2025,P020823A, Exp. Date 2/8/2025, P020923A, Exp. Date 2/9/2025, P021323A, Exp. Date 2/13/2025;  P021523A, P021523B, Exp. Date  2/15/2025, P021623A, Exp. Date 2/16/2025, P022023A, Exp. Date 2/20/2025, P022123A, Exp. Date 2/21/2025, P022323A, Exp. Date 2/23/2025, P022723A, Exp. Date 2/27/2025, P030123A, Exp. Date 3/1/2025, P030223A, Exp. Date 3/2/2025, P030623A, Exp. Date 3/6/2025; P030723A, Exp. Date 3/7/2025; P030823A, Exp. Date 3/8/2025; P030923A Exp. Date 3/9/2025, P031423A, Exp. Date 3/14/2025, P032023A, Exp. Date 3/20/2025, P032123A, Exp. Date 3/21/2025; P032223A, Exp. Date 3/22/2025; P032723A, Exp. Date 3/27/2025; P040423A, Exp. Date 4/4/2025; P040523A, Exp. Date 4/5/2025; P040623A, Exp. Date 4/6/2025; P041023A, Exp. Date 4/10/2025;P041123A, Exp. Date 4/11/2025; P041223A, Exp. Date 4/12/2025; P041323A, Exp. Date 4/13/2025; P041723A, Exp. Date 4/17/2025; P041823A, Exp. Date 4/18/2025;P041923A, Exp. Date 4/19/2025; P042023A, Exp. Date 4/20/2025; P042423A, Exp. Date 4/24/2025; P042523A, Exp. Date 4/25/2025;P042623A, Exp. Date 4/26/2025; P050323A, Exp. Date 5/3/2025; P050823A, Exp. Date 5/8/2025;P050923A, Exp. Date 5/9/2025;P051023A, Exp. Date 5/10/2025;P051123A, Exp. Date 5/11/2025;P051523A, Exp. Date 5/15/2025; P051623A, Exp. Date 5/16/2025; P051723A, Exp. Date 5/17/2025; P052223A, Exp.: 5/22/2025; P052323A, Exp.: 5/23/2025; P052423A, Exp. Date 5/24/2025; P052523A, Exp.: 5/25/2025; P053023A, Exp. Date 5/30/2025; P053123A, Exp. Date 5/31/2025; P060123A, Exp. Date 6/1/2025; P060223A, Exp. Date 6/2/2025; P060523A, Exp. Date 6/5/2025; P060623A, Exp. Date 6/6/2025; P060723A, Exp. Date 6/7/2025; P060823A, Exp. Date 6/8/2025; P061223A, Exp. Date 6/12/2025; P061323A, Exp. Date 6/13/2025; P061423A, Exp. Date 6/14/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74057", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1419-2016", "product_description": "4 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride\t50 mL in 60 mL Monoject Syringe,   Service Code 2K8983, Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-983-48", "product_quantity": "3,828 syringes", "reason_for_recall": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.", "recall_initiation_date": "20160505", "center_classification_date": "20160716", "termination_date": "20180306", "report_date": "20160727", "code_info": "Service Code 2H8267 , Lot Number 160630024M , Exp. Date 5/28/2016 ;  Service Code 2K8128 , Lot Number 160490252M , Exp. Date 5/13/2016 ;  Service Code 2K8128 , Lot Number 160530274M , Exp. Date 5/17/2016 ;  Service Code 2K8128 , Lot Number 160600213M , Exp. Date 5/24/2016 ;  Service Code 2K8128 , Lot Number 160660184M , Exp. Date 5/30/2016 ;  Service Code 2K8128 , Lot Number 160730236M , Exp. Date 6/6/2016 ;  Service Code 2K8128 , Lot Number 160810218M , Exp. Date 6/14/2016 ;  Service Code 2K8128 , Lot Number 160820186M , Exp. Date 6/15/2016 ;  Service Code 2K8128 , Lot Number 160940172M , Exp. Date 6/27/2016 ;  Service Code 2K8267 , Lot Number 160450259M , Exp. Date 5/15/2016 ;  Service Code 2K8267 , Lot Number 160540156M , Exp. Date 5/24/2016 ;  Service Code 2K8267 , Lot Number 160600323M , Exp. Date 5/30/2016 ;  Service Code 2K8267 , Lot Number 160660257M , Exp. Date 6/5/2016 ;  Service Code 2K8267 , Lot Number 160730258M , Exp. Date 6/12/2016 ;  Service Code 2K8267 , Lot Number 160770130M , Exp. Date 6/16/2016 ;  Service Code 2K8267 , Lot Number 160840132M , Exp. Date 6/23/2016 ;  Service Code 2K8267 , Lot Number 160900007M , Exp. Date 6/28/2016 ;  Service Code 2K8267 , Lot Number 160970143M , Exp. Date 7/6/2016 ;  Service Code 2K8267 , Lot Number 161080249M , Exp. Date 7/17/2016 ;  Service Code 2K8638 , Lot Number 160410229M , Exp. Date 5/11/2016 ;  Service Code 2K8638 , Lot Number 160420200M , Exp. Date 5/12/2016 ;  Service Code 2K8638 , Lot Number 160460214M , Exp. Date 5/16/2016 ;  Service Code 2K8638 , Lot Number 160480210M , Exp. Date 5/17/2016 ;  Service Code 2K8638 , Lot Number 160490254M , Exp. Date 5/19/2016 ;  Service Code 2K8638 , Lot Number 160490255M , Exp. Date 5/19/2016 ;  Service Code 2K8638 , Lot Number 160520127M , Exp. Date 5/22/2016 ;  Service Code 2K8638 , Lot Number 160600310M , Exp. Date 5/30/2016 ;  Service Code 2K8638 , Lot Number 160630164M , Exp. Date 6/2/2016 ;  Service Code 2K8638 , Lot Number 160670272M , Exp. Date 6/6/2016 ;  Service Code 2K8638 , Lot Number 160750259M , Exp. Date 6/14/2016 ;  Service Code 2K8638 , Lot Number 160770264M , Exp. Date 6/16/2016 ;  Service Code 2K8638 , Lot Number 160840238M , Exp. Date 6/23/2016 ;  Service Code 2K8638 , Lot Number 160870197M , Exp. Date 6/26/2016 ;  Service Code 2K8638 , Lot Number 160950189M , Exp. Date 7/4/2016 ;  Service Code 2K8983 , Lot Number 160530047C , Exp. Date 5/14/2016 ;  Service Code 2K8983 , Lot Number 160740088C , Exp. Date 6/4/2016 ;  Service Code 2K8983 , Lot Number 160880066C , Exp. Date 6/18/2016 ;  Service Code 2K8983 , Lot Number 160970040C , Exp. Date 6/27/2016 ;", "more_code_info": ""}, {"country": "United States", "city": "Huntsville", "address_1": "120 Vintage Dr NE", "reason_for_recall": "Failed Dissolution Specifications: During routine stability testing  at the 12 month time point, one product lot was found to be  out of specification for dissolution.", "address_2": "", "product_quantity": "2016 bottles", "code_info": "Lot #: T142A14A, T143A14A, T144A14A, Exp 01/16", "center_classification_date": "20150630", "distribution_pattern": "Nationwide", "state": "AL", "product_description": "Disulfiram tablets, USP, 500 mg, 100-count bottles, Rx only, Manufactured for and by Qualitest Pharmaceuticals 130 Vintage Drive Huntsville, AL  35811. NDC 0603-3432-21.", "report_date": "20150708", "classification": "Class III", "openfda": {}, "recalling_firm": "Qualitest Pharmaceuticals", "recall_number": "D1151-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "71563", "termination_date": "20161023", "more_code_info": "", "recall_initiation_date": "20150618", "postal_code": "35811-8216", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205927"], "brand_name": ["PRASUGREL"], "generic_name": ["PRASUGREL"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-5185", "0378-5186"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRASUGREL HYDROCHLORIDE"], "rxcui": ["855812", "855818"], "spl_id": ["9e234352-49b7-46e3-bc59-acf63e0a7a14"], "spl_set_id": ["41a4e332-6725-4cb7-940a-8291cf56cfe4"], "package_ndc": ["0378-5185-93", "0378-5186-93"], "is_original_packager": [true], "upc": ["0303785185932"], "unii": ["G89JQ59I13"]}, "product_type": "Drugs", "event_id": "84039", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0155-2020", "product_description": "Prasugrel Tablets 5 mg, 30-count bottles, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A, NDC 0378-5185-93", "product_quantity": "4,272 bottles", "reason_for_recall": "Failed Dissolution Specification: Low out of specification dissolution results.", "recall_initiation_date": "20191018", "center_classification_date": "20191028", "termination_date": "20200410", "report_date": "20191106", "code_info": "Lot #: 3089793, Exp. Date September 2020", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA207932"], "brand_name": ["BELBUCA"], "generic_name": ["BUPRENORPHINE HYDROCHLORIDE"], "manufacturer_name": ["BioDelivery Sciences International Inc"], "product_ndc": ["59385-021", "59385-022", "59385-023", "59385-024", "59385-025", "59385-026", "59385-027"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["BUCCAL"], "substance_name": ["BUPRENORPHINE HYDROCHLORIDE"], "rxcui": ["1716057", "1716063", "1716065", "1716067", "1716069", "1716071", "1716073", "1716075", "1716077", "1716079", "1716081", "1716083", "1716086", "1716090"], "spl_id": ["d8541d8a-992a-4b62-8518-ecd85f480e67"], "spl_set_id": ["bc2b7a3d-72cf-497c-95b0-ba2b71f63c64"], "package_ndc": ["59385-021-01", "59385-021-60", "59385-022-01", "59385-022-60", "59385-023-01", "59385-023-60", "59385-024-01", "59385-024-60", "59385-025-01", "59385-025-60", "59385-026-01", "59385-026-60", "59385-027-01", "59385-027-60"], "is_original_packager": [true], "unii": ["56W8MW3EN1"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0449-2021", "product_description": "Belbuca (buprenorphine hydrochloride) buccal film 600 mcg 60 pouches containing 1 buccal film each Rx only NDC 59385-025-60 Manufactured for: BioDelivery Sciences International, Inc. Raleigh, NC 27612 USA", "product_quantity": "47 cartons", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "BL6002004"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-039-2014", "product_description": "Aminophylline 250mg 10ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "6 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0110-2016", "product_description": "METHYLCOBALAMIN/HYDROXOCOBALAMIN PRESERVATIVE FREE UNIT DOSE SYRINGES, Injectable Solution, 2.5/0. 5MG/ML, 20 mL syringe, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "1 syringe", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t09232014@24, t03122015@11"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA203813"], "brand_name": ["CANDESARTAN"], "generic_name": ["CANDESARTAN"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-114", "33342-115", "33342-116", "33342-117"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CANDESARTAN CILEXETIL"], "rxcui": ["153822", "153823", "577776", "639537"], "spl_id": ["4079c843-42ee-4f7a-a4a0-9498ba6cf12d"], "spl_set_id": ["8ceb5658-b03c-475d-9ef0-2cd0645191d3"], "package_ndc": ["33342-114-07", "33342-114-51", "33342-114-12", "33342-114-10", "33342-115-07", "33342-115-51", "33342-115-12", "33342-115-10", "33342-116-07", "33342-116-51", "33342-116-12", "33342-116-10", "33342-117-07", "33342-117-51", "33342-117-12", "33342-117-10"], "is_original_packager": [true], "upc": ["0333342117106", "0333342116109", "0333342114105", "0333342114075", "0333342116079", "0333342117076", "0333342115072", "0333342114129", "0333342115102", "0333342117120", "0333342115126", "0333342116123"], "unii": ["R85M2X0D68"]}, "product_type": "Drugs", "event_id": "87607", "recalling_firm": "Macleods Pharma Usa Inc", "address_1": "666 Plainsboro Rd Bldg 200 Ste 230", "address_2": "N/A", "postal_code": "08536-0009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0329-2021", "product_description": "Candesartan Cilexetil Tablets, USP, 4 mg, 30-count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., Daman (U.T.), India, NDC 33342-114-10", "product_quantity": "8015 packs", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20210322", "center_classification_date": "20210412", "termination_date": "20221213", "report_date": "20210421", "code_info": "Lots # : ECD5908C, Exp 7/2021; ECD5909A, ECD5910A,   ECD5911A, ECD5912A, Exp. 09/2021."}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0037-2022", "product_description": "ESTRADIOL VALERATE 5MG/ML MDV INJ, Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}, {"country": "United States", "city": "Mount Vernon", "address_1": "144 Kingsbridge Road East", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.", "address_2": "", "product_quantity": "9,948 tubes: 3 oz(8,832), 7 oz(1,116)", "code_info": "Lot #: a)1502156, 1507104            b)1503039, 1507001", "center_classification_date": "20151127", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "Carbo-O-Philic 40 Cream 40% (Urea) tubes, a) 3 oz (85 g) (NDC 54162-640-03) , b) 7 oz (200 g) (NDC 54162-640-07), Rx Only For topical use only, Distributed by Geritrex Corporation, East Mount Vernon, NY 10550", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Geritrex Corp", "recall_number": "D-0390-2016", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "72509", "termination_date": "20180611", "more_code_info": "", "recall_initiation_date": "20151027", "postal_code": "10550", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77191", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0906-2017", "product_description": "Potassium CHLORide added to 0.9% Sodium Chloride, 30mEq 100 mL Bag, Service Code 2K5824, NDC# 61553-0824-48, Total Volume 100.00 mL  incorrectly labeled as 115.00 mL, Rx Only, PharMEDium Services, LLC, 6100 Global Drive, Memphis, TN 38141", "product_quantity": "216 bags", "reason_for_recall": "Labeling: Not Elsewhere Classified: Incorrect volume printed on the product label.", "recall_initiation_date": "20170217", "center_classification_date": "20170612", "termination_date": "20170613", "report_date": "20170621", "code_info": "Lot Numbers:  70090135M, 2/27/2017; 170250101M, 3/15/2017; 170030011D, 4/4/2017; 170040078D, 4/5/2017; 170310012D, 5/2/2017; 170400046D, 5/11/2017;"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "161 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  03242015@21, 5/23/2015; 04132015@32, 6/12/2015; 04172015@45, 6/16/2015; 05052015@40, 7/4/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "HCG 1,100 IU/ml + Methylcobalamin 0.5 mg/ml Injection, ml Multi-Dose Vial, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1509-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "San Diego", "address_1": "3978 Sorrento Valley Blvd Ste 300", "reason_for_recall": "Lack of Processing Controls: products produced in a manner that calls into question the sterility of the drug product intended to be sterile.", "address_2": "", "product_quantity": "191 vials", "code_info": "Lot #: 144326@3, Exp 07/10/2018; 145953@2, Exp 08/05/2018", "center_classification_date": "20180713", "distribution_pattern": "Product was distributed to patients via patient specific prescription only in CA.", "state": "CA", "product_description": "Glutathione 200mg/mL Injection w/Pres. (Benzyl Alcohol 1.5% in Sterile Water), 30 mL vial, Rx only, la VITA Compounding Pharmacy, 858.453.2500", "report_date": "20180725", "classification": "Class II", "openfda": {}, "recalling_firm": "La Vita Compounding Pharmacy, LLC", "recall_number": "D-0923-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80416", "termination_date": "20190118", "more_code_info": "", "recall_initiation_date": "20180625", "postal_code": "92121-1436", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0315-2023", "product_description": "PIPERACILLIN / TAZOBACTAM (a) 4.5GM IN NS 100 ML, (b)18GM IN NS 267M, (c) 27GM IN NS 400ML, (d) 3.375 GM IN NS 50ML, (e) 36 GM IN NS 533 ML,  antibiotic, Rx only, use with a Curlin or home pump or no pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320", "product_quantity": "78 bags", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 25-31, 2022"}, {"status": "Terminated", "city": "Lincoln", "state": "NE", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "65840", "recalling_firm": "Novartis Consumer Health", "address_1": "10401 Hwy 6", "address_2": "N/A", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Canada, and Panama.", "recall_number": "D-907-2013", "product_description": "Maalox, Regular Strength Antacid (calcium carbonate) chewable tablets, 600 mg, Wintergreen flavor, 50-count tablets per bottle, Novartis Consumer Health Canada Inc., Mississauga, ON  L5N 2X7, foreign labeling containing English and French, NPN 02238290, UPC 0 58478 44824 4.", "product_quantity": "46,680 bottles", "reason_for_recall": "Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.", "recall_initiation_date": "20130806", "center_classification_date": "20130820", "termination_date": "20141104", "report_date": "20130828", "code_info": "Lot #: 10095534, Exp 07/13; 10114311, Exp 04/14"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: DEXAMETHASONE, Tablet, 1 mg may have potentially been mislabeled as the following drug:  VENLAFAXINE HCL ER, Capsule, 150 mg, NDC 00093738656, Pedigree: AD30993_20, EXP: 5/9/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "DEXAMETHASONE, Tablet, 1 mg has the following codes:   Pedigree: AD37088_1, EXP: 5/9/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DEXAMETHASONE, Tablet, 1 mg, Rx only, Distributed by Aidapack Service, LLC, NDC 00054418125.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-798-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Allegan", "address_1": "515 Eastern Ave", "reason_for_recall": "CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.", "address_2": "", "product_quantity": "", "code_info": "Lots:  8FE1455,   8GE1343,   8HE1225,   8KE2834,   8KE2249,   8ME2730,   9AE2838,   9EE2639,   9FE2993", "center_classification_date": "20200313", "distribution_pattern": "Nationwide USA", "state": "MI", "product_description": "Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 160 tablets per bottle. [NDC: Brand] NDC CVS Health.: 69842-293-06", "report_date": "20200325", "classification": "Class II", "openfda": {}, "recalling_firm": "Perrigo Company PLC", "recall_number": "D-1016-2020", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "84127", "termination_date": "20201106", "more_code_info": "", "recall_initiation_date": "20191023", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0851-2023", "product_description": "Tobramycin Ophthalmic Solution, USP 0.3%, 5mL bottles, Rx only, Manufactured by: Akorn , Inc, Lake Forest, IL 60045. ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Melrose Park", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA006488"], "brand_name": ["XYLOCAINE"], "generic_name": ["LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-481", "63323-492", "63323-491", "63323-495", "63323-485", "63323-486", "63323-484", "63323-489", "63323-488", "63323-483", "63323-482", "63323-487"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INFILTRATION", "PERINEURAL"], "substance_name": ["EPINEPHRINE BITARTRATE", "LIDOCAINE HYDROCHLORIDE ANHYDROUS"], "rxcui": ["1010033", "1010035", "1010671", "1010673", "1010688", "1010692", "1010745", "1010749", "1010751", "1010755", "1010759", "1010763", "1010900", "1010902", "1737343", "1737345", "1737562", "1737563", "1737566", "1737567", "1737568", "1737569", "1737570", "1737571", "1737757", "1737758", "1737761", "1737762", "1867938", "1867940", "1867943", "1867944", "1867992", "1867993", "1867996", "1867997", "1868028", "1868029"], "spl_id": ["ea480a68-5927-4278-9deb-2956961da428"], "spl_set_id": ["ba082c2f-64f4-419d-9c88-74f203316e17"], "package_ndc": ["63323-492-04", "63323-492-27", "63323-492-09", "63323-492-57", "63323-492-07", "63323-492-37", "63323-492-03", "63323-492-31", "63323-491-01", "63323-491-57", "63323-495-09", "63323-495-27", "63323-495-04", "63323-495-07", "63323-485-01", "63323-485-27", "63323-485-03", "63323-485-57", "63323-486-01", "63323-486-17", "63323-486-02", "63323-486-27", "63323-486-05", "63323-486-57", "63323-484-57", "63323-489-02", "63323-489-27", "63323-489-03", "63323-489-21", "63323-489-01", "63323-489-17", "63323-488-07", "63323-488-37", "63323-488-03", "63323-488-31", "63323-488-01", "63323-488-17", "63323-481-01", "63323-481-57", "63323-483-03", "63323-483-27", "63323-483-01", "63323-483-57", "63323-482-01", "63323-482-17", "63323-482-03", "63323-482-27", "63323-482-05", "63323-482-57", "63323-487-01", "63323-487-17", "63323-487-07", "63323-487-37", "63323-487-03", "63323-487-31"], "is_original_packager": [true], "upc": ["0363323484576", "0363323485016", "0363323483036", "0363323487072", "0363323486013", "0363323495091", "0363323488079", "0363323489021", "0363323495046", "0363323491017", "0363323492045", "0363323492090", "0363323482015", "0363323481018"], "unii": ["EC2CNF7XFP", "30Q7KI53AK"]}, "product_type": "Drugs", "event_id": "88194", "recalling_firm": "Fresenius Kabi USA LLC", "address_1": "2020 N Ruby St", "address_2": "", "postal_code": "60160-1112", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0651-2021", "product_description": "Xylocaine-MPF with Epinephrine 1:200,000, (Lidocaine HCl and Epinephrine Injection, USP), 1%, 300 mg/30 mL, (10 mg/mL), 30 mL Single Dose Vial, 25 Vials per Tray, Rx only, Fresenius Kabi USA, LLC, Lake Zurich, IL 60047. Vial NDC  63323-487-07, Tray NDC 63323-487-37", "product_quantity": "234,800 vials", "reason_for_recall": "Low out of specification results for epinephrine assay.", "recall_initiation_date": "20210625", "center_classification_date": "20210707", "termination_date": "20221228", "report_date": "20210714", "code_info": "Batch, expiry: Batch 6123435, exp 01/2022; 6124730, 6124731, exp 07/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Charlotte", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82620", "recalling_firm": "CMC Enterprise Pharmacy", "address_1": "4400 Golf Acres Dr", "address_2": "N/A", "postal_code": "28208-5968", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NC", "recall_number": "D-1222-2019", "product_description": "Lidocaine 1% - Sodium Bicarb 8.4% 10:1, 10 mL syringe, For Intradermal Use Only, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.", "product_quantity": "40 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190412", "center_classification_date": "20190423", "termination_date": "20191030", "report_date": "20190501", "code_info": "Lots: ED051902 Exp. 4/14/2019; ED101902 Exp. 4/19/2019"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019339"], "brand_name": ["HEPARIN SODIUM AND DEXTROSE"], "generic_name": ["HEPARIN SODIUM"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-4520", "0409-7793", "0409-7794"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["HEPARIN SODIUM"], "rxcui": ["1658717"], "spl_id": ["0fb90002-cf4c-4da3-9cca-ea8b1394d34c"], "spl_set_id": ["eede8a0c-5ae6-4166-84b3-12081405f08e"], "package_ndc": ["0409-7793-52", "0409-7793-62", "0409-7793-13", "0409-7793-23", "0409-7794-52", "0409-7794-62", "0409-4520-02", "0409-4520-30"], "is_original_packager": [true], "unii": ["ZZ45AB24CA"]}, "product_type": "Drugs", "event_id": "68631", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1425-2014", "product_description": "Heparin Sodium in 5% Dextrose Injection, Heparin, 25,000 USP Heparin Units/250 mL (100 USP Heparin Units/mL), 250 mL, Single-Dose Container, Hospira, Inc., Lake Forest, IL 60045 USA,  NDC 0409-7793-62", "product_quantity": "142,152 bags", "reason_for_recall": "Lack of Assurance of Sterility: Confirmed consumer report of fluid leaking from primary container of bag.", "recall_initiation_date": "20140606", "center_classification_date": "20140709", "termination_date": "20150403", "report_date": "20140716", "code_info": "Lot # 34-811-KL, 36-106-KL, 36-114-KL; Exp. 12/15; 36-101-KL, Exp. 12/15; 37-202-KL, Exp. 1/16; 38-302-KL, Exp. 2/16; 38-305-KL, Exp. 2/16", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88442", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed Nationwide, including Puerto Rico.", "recall_number": "D-0734-2021", "product_description": "Idarubicin Hydrochloride Injection 20 mg/20 mL, 20 mL single-dose vial, Rx only, Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0703-4156-11", "product_quantity": "2,091 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210729", "center_classification_date": "20210816", "termination_date": "20240604", "report_date": "20210825", "code_info": "Lot #: 31328668B, exp. date 04/2023"}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85903", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "N/A", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Puerto Rico, Guam, United Arab Emirates, Bahrain, Brazil, Democratic Republic of the Congo, Chile, Colombia, United Kingdom of Great Britain and Northern Ireland, Hong Kong, Israel, Kuwait, Oman, Qatar, Saudi Arabia, Singapore,", "recall_number": "D-1510-2020", "product_description": "ChloraPrep With Tint (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)) 3 mL applicators - Hi-Lite Orange  25 applicators in carton, CareFusion El Paso, TX 79912, subsidiary of Becton, Dickinson and Company, NDC 054365-400-11", "product_quantity": "2,800,800 applicators", "reason_for_recall": "Non-Sterility: Product is being recalled due to presence of Aspergillus Penicilloides", "recall_initiation_date": "20200623", "center_classification_date": "20200819", "termination_date": "20220928", "report_date": "20200826", "code_info": "Lot #: 7194739, Exp. 06/25/2020; 7214841, Exp. Date 07/17/2020; 7213558, Exp. Date 07/16/2020; 7227839, Exp. Date 07/30/2020; 7276589, Exp. Date 09/20/2020; 7198824, Exp. Date 06/29/2020; 7275718, Exp. Date 09/19/2020; 7289776, Exp. Date 09/30/2020; 7306916, Exp. Date 10/12/2020; 8011665, Exp. Date 12/14/2020; 8015801, Exp. Date 12/18/2020; 8031857, Exp. Date 01/31/2021; 8033645, Exp. Date 01/31/2021; 8127657, Exp. Date 04/30/2021; 8137527, 8157141, 8158638, Exp. Date 05/31/2021; 8164530, Exp. Date 06/30/2021; 8220737, Exp. Date 07/31/2021; 8235991, Exp. Date 08/31/2021; 8043978, Exp. Date 01/31/2021; 8306694, Exp. Date 10/31/2021; 8334983, Exp. Date 11/30/2021; 9031893, 9038599, 9042938, Exp. Date 01/31/2022; 9051563, 9053560, 9072856, Exp. Date 02/28/2022; 9086532, Exp. Date 03/31/2022; 9137904, Exp. Date 05/31/2022; 9087985, Exp. Date 03/31/2022; 9191256, 9168975, Exp. Date 06/30/2022; 9218464, 9218595, Exp. Date 07/31/2022; 9228305, 9241932, 9247742, 9249471, Exp. Date 08/31/2022; 9269603, Exp. Date 09/30/2022; 9296395, 9295914, 9311076, Exp. Date 10/31/2022; 9316348, 9324565, 9345911, Exp. Date 11/30/2022; 9305775, Exp. Date 10/31/2022; 0011737, Exp. Date 12/31/2022; 0023790, 0037279, Exp. Date 01/31/2023."}, {"status": "Terminated", "city": "Daphne", "state": "AL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88289", "recalling_firm": "API Solutions Inc.", "address_1": "25309 Friendship Rd", "address_2": "N/A", "postal_code": "36526-6278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AL, AZ, CO, FL, VA", "recall_number": "D-0695-2021", "product_description": "Estriol USP41 Micro 25 Grams, Distributed by: A.P.I. Solutions 25309 Friendship Rd Daphne, AL  Distributed by: Syntec Pharma Corp., NY MFT by: Wuhan Fortune Chemical Co., Ltd., China, NDC: 46144-300-01", "product_quantity": "20 bottles", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20210715", "center_classification_date": "20210728", "termination_date": "20220208", "report_date": "20210804", "code_info": "Lot #: ETL181001, Exp 10/09/2021"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0376-2017", "product_description": "MIC+B12(M)+Carnitine 12.5 mg/50 mg/100 mg/1 mg/50 mg/mL Injectable, 30 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "159", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 03252016@5, 04192016@8, 05242016@15, 06222016@28, 08102016@2."}, {"country": "United States", "city": "Mount Vernon", "address_1": "144 Kingsbridge Road East", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.", "address_2": "", "product_quantity": "3,796 jars (8.4 oz) 3,204, (16.9 oz) 3,350", "code_info": "Lot #: a) 1201092, 1403053, 1210028, 1007059, 1112105, 1305044, 1303079, 1406098, 1407061, 1505037, 1412004  1408081,  b) 1112105 & 1007036", "center_classification_date": "20151127", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "Polyethylene Glycol 3350-GRX Powder 100% jars a)  8.4 oz (250 g) (NDC 54162-335-02), b) Net wt. 16.9 oz  (500 g) (NDC 54162-335-05), Distributed by: Geritrex Corporation, Mount Vernon, NY 10550", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Geritrex Corp", "recall_number": "D-0393-2016", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "72509", "termination_date": "20180611", "more_code_info": "", "recall_initiation_date": "20151027", "postal_code": "10550", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Aurora", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71535", "recalling_firm": "the Compounder", "address_1": "340 Marshall Ave Unit 100", "address_2": "N/A", "postal_code": "60506-5649", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0198-2016", "product_description": "BIEST TD 80/20 (Estradiol (E2) Trit (Yellow)/Estriol USP Micronized (E3) : PROG (Progesterone USP Micronized) : DHEA (Dehydroepiandrosterone Micronized) : TESTO (Testosterone Trit) W/V (weight/volume) VERSABASE 5.0 : 30 : 2.5 : 0.25 MG/ML Transdermal cream, dispensed in 10 mL prefilled, amber syringes, Rx only,   The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.", "product_quantity": "26 (10mL) syringes", "reason_for_recall": "Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.", "recall_initiation_date": "20150310", "center_classification_date": "20151110", "termination_date": "20160519", "report_date": "20151118", "code_info": "Lot # 12172014:08@24, Exp 6/15/2015"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86343", "recalling_firm": "RLC Labs Inc.", "address_1": "1850 E Riverview Dr", "address_2": "N/A", "postal_code": "85034-6703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-1596-2020", "product_description": "Nature-Throid, Thyroid USP [liothyronine (T3) 9 mcg and levothyroxine (T4) 38 mcg], 1 Grain (65 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-3300-4; b) 60-count bottles, NDC 64727-3300-5; c) 90-count bottles, NDC 64727-3300-6; d) 100-count bottles, NDC 64727-3300-1; and e) 1,000-count bottles, NDC 64727-3300-2; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: manufactured under the same conditions as those found to be subpotent.", "recall_initiation_date": "20200825", "center_classification_date": "20200924", "termination_date": "20231108", "report_date": "20200923", "code_info": "All lots with expiry between 10/2020-07/2023"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1066-2023", "product_description": "PHENYLephrine in 0.9% sodium chloride, 1000 mcg/10 mL, (100 mcg/mL), 10 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6009-1", "product_quantity": "81,073 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270449, 17-270450, 17-270453, 17-270462, 17-270465, 17-270466, 17-270494, 17-270495, 17-270502, 17-270541, Exp. 7/16/2023; 17-270582, 17-270585, 17-270587, 17-270592, 17-270593, 17-270598, 17-270610, 17-270611, 17-270612, Exp. 7/17/2023; 17-270900, 17-270902, 17-270906, 17-270907, 17-270908, 17-270909, 17-270953, 17-270955, 17-270991, 17-270993, Exp. 7/23/2023; 17-271047, 17-271048, 17-271050, 17-271053, Exp. 7/24/2023; 17-271344, 17-271349, 17-271355, 17-271356, 17-271405, 17-271406, Exp. 7/31/2023; 17-271478, 17-271479, 17-271480, 17-271484, 17-271495, 17-271500, Exp. 7/31/2023; 17-271744, 17-271763, Exp. 8/3/2023; 17-271838, 17-271851, Exp. 8/6/2023; 17-271871, 17-271873, 17-271886, 17-271887, 17-271892, 17-271899, 17-271900, 17-271901, 17-271902, Exp. 8/7/2023; 17-272067, 17-272068, 17-272069, 17-272095, Exp. 8/9/2023; 17-272102, 17-272141, 17-272142, Exp. 8/10/2023; 17-272205, 17-272235, 17-272237, 17-272240, 17-272242, Exp. 8/13/2023; 17-272307, 17-272308, Exp. 8/14/2023; 17-272391, 17-272392, 17-272395, Exp. 8/15/2023; 17-272472, Exp. 8/16/2023; 17-272538, Exp. 8/17/2023; 17-272558, 17-272560, 17-272564, 17-272593, 17-272594, 17-272618, 17-272619, 17-272651, 17-272653, 17-272680, Exp. 8/20/2023; 17-272697, 17-272727, 17-272729, Exp. 8/21/2023; 17-272775, 17-272791, 17-272820, 17-272821, Exp. 8/22/2023; 17-272904, 17-272918, 17-272919, 17-272920, 17-272921, 17-272929, Exp. 8/23/2023; 17-272930, 17-272974, 17-272993, 17-272994, 17-272995, 17-272996, Exp. 8/24/2023; 17-272999, 17-273003, 17-273004, 17-273005, 17-273006, 17-273007, Exp. 8/27/2023; 17-273080, Exp. 8/28/2023; 17-273151, 17-273175, 17-273176, 17-273185, Exp. 8/29/2023; 17-273252, 17-273265, 17-273266, Exp. 8/30/2023; 17-273345, 17-273351, 17-273352, 17-273355, 17-273356, 17-273358, 17-273359, 17-273360, Exp. 8/31/2023; 17-273402, 17-273408, 17-273416, 17-273440, 17-273441, 17-273447, Exp. 9/3/2023; 17-273487, 17-273488, 17-273489, 17-273490, 17-273491, 17-273499, 17-273510, 17-273516, Exp. 9/4/2023; 17-273587, 17-273589, 17-273596, 17-273597, 17-273610, 17-273614, 17-273666, Exp. 9/5/2023; 17-273617, 17-273665, 17-273703, 17-273704, 17-273713, 17-273714, 17-273720, 17-273721, 17-273730, 17-273737, 17-273739, Exp. 9/6/2023; 17-273773, Exp. 9/7/2023; 17-273802, 17-273803, 17-273808, 17-273809, 17-273815, 17-273848, 17-273869, 17-273874, 17-273880, 17-273881, 17-273893, Exp. 9/10/2023; 17-273903, 17-273958, 17-273960, 17-273961, 17-273964, 17-273965, Exp. 9/11/2023."}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "4000 mL in Vials", "code_info": "a) Lot #: 151130-66, BUD: 05/28/16;  Lot #: 160222-51, BUD: 08/20/16.  b) Lot #: 151130-60, BUD: 05/28/16;  Lot #: 160222-51, BUD: 08/20/16.", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "B-COMPLEX WITHOUT B12 (PF) IN NACL 0.9%, B1-100MG, B2-5-PO4-2MG, B3-50MG, B5-2MG, B6-2MG/ML, In a) 2ML Vials and b) 5ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1170-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0831-2019", "product_description": "Dr. King's SafeCare Rx Allergies: Nuts & Seeds, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955220428, NDC 57955-2204-2", "product_quantity": "97 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 082815A Exp. 08/18; 112117D Exp. 11/19; 061416A Exp. 06/19"}, {"status": "Ongoing", "city": "Skillman", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88288", "recalling_firm": "Johnson & Johnson Consumer, Inc.", "address_1": "199 Grandview Rd", "address_2": "N/A", "postal_code": "08558-1311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in US", "recall_number": "D-0837-2021", "product_description": "Neutrogena Ultra Sheer body mist sunscreen BROAD SPECTRUM SPF 45, Avobenzone (3%), Homosalate (10%), Octisalate (5%), Octocrylene (10%), a) Net Wt. 5 OZ (141 g) (UPC 0 86800 10039 3) and b) Net Wt. 8.0 oz. (226 g) (UPC 0 86800 11134 4) aerosol can, Distributed by: JOHNSON & JOHNSON CONSUMER, INC. Skillman, NJ, 08858,", "product_quantity": "a) 5oz-1,282,488; b) 8oz-475,476 cans", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20210714", "center_classification_date": "20210924", "report_date": "20211006", "code_info": "All lots within expiry."}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203701"], "brand_name": ["ACYCLOVIR SODIUM"], "generic_name": ["ACYCLOVIR SODIUM"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-154", "55150-155"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ACYCLOVIR SODIUM"], "rxcui": ["1734932", "1734934"], "spl_id": ["410e306b-e8b9-4ff5-b703-a3005eec272f"], "spl_set_id": ["ae921e4e-b8ae-4a45-acc1-32e5e719812b"], "package_ndc": ["55150-154-10", "55150-155-20"], "is_original_packager": [true], "upc": ["0355150155200", "0355150154104"], "unii": ["927L42J563"]}, "product_type": "Drugs", "event_id": "91406", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0095-2023", "product_description": "Acyclovir Sodium Injection 1,000 mg per 20 mL* (50 mg/mL); Single Dose 20mL Vial, Rx only,  Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd, E. Windsor, NJ 08520; Made in India. NDC 55150-155-20", "product_quantity": "45,250 vials", "reason_for_recall": "Presence of Particulate Matter: Customer complaint of dark particles found inside the vial", "recall_initiation_date": "20221228", "center_classification_date": "20230103", "report_date": "20230111", "code_info": "Lot # AC22004, Expiry: 08/2023"}, {"status": "Terminated", "city": "Roseburg", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81883", "recalling_firm": "Hiers Enterprises, LLC dba Northwest Compounding Pharmacy", "address_1": "1350 Ne Stephens St Ste 42", "address_2": "N/A", "postal_code": "97470-6410", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed exclusively in the state of Oregon to 3 Medical facilities, 1 Physician's office and 80 consumers/patients.    These are compounded products - labels vary for each compound - specific to each patient.  Firm did not provide labeling.", "recall_number": "D-0407-2019", "product_description": "Glutathione liquid, 200mg/ml, Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190102", "center_classification_date": "20190127", "termination_date": "20230328", "report_date": "20190109", "code_info": "10092018@5"}, {"country": "United States", "city": "Columbus", "address_1": "2550 John Glenn Ave", "reason_for_recall": "Failed USP Dissolution Test Requirements: This sub-recall is in response to Prometheus Laboratories Inc. recall for Mercaptopurine USP 50mg because the lot does not meet the specification for dissolution.", "address_2": "Suite A", "product_quantity": "3496 cartons", "code_info": "Lot #: 142450 Exp 05/2015; 140862 Exp 02/2015; 141596 Exp 03/2015; 134770 Exp 01/2015", "center_classification_date": "20141216", "distribution_pattern": "Nationwide.", "state": "OH", "product_description": "Mercaptopurine Tablets, USP, 50 mg, 30 Tablets (3 x 10) unit dose blisters per carton, Rx only, Manufactured by Prometheus Laboratories Inc. 9410 Carroll Park Drive, San Diego, CA 92121, repackaged by American Health Packaging 2550-A John Glenn Avenue, Columbus, OH 43217, NDC 68084-325-21", "report_date": "20141224", "classification": "Class II", "openfda": {}, "recalling_firm": "American Health Packaging", "recall_number": "D-0300-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "69972", "termination_date": "20150601", "recall_initiation_date": "20141119", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lawrence", "state": "KS", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "90398", "recalling_firm": "Plastikon Healthcare LLC", "address_1": "3780 Greenway Cir", "address_2": "N/A", "postal_code": "66046-5440", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1478-2022", "product_description": "Magnesium Hydroxide 1200 mg, Aluminum Hydroxide 1200 mg, Simethicone 120 mg per 30 mL, 30 mL cup, packaged in 10 cups per tray, 10 trays per carton, For Institutional Use Only, Major Pharmaceuticals, 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152, NDC 0904-6838-73", "product_quantity": "220,500 cups", "reason_for_recall": "Microbial Contamination of Non-Sterile Products.", "recall_initiation_date": "20220607", "center_classification_date": "20220906", "termination_date": "20250625", "report_date": "20220914", "code_info": "Lot# 20076A, EXP Jul. 2022, 20079A, 20081A, EXP Aug. 2022; 21096A, EXP Oct. 2022; 21115A, 21103A, EXP Sep. 2022."}, {"status": "Terminated", "city": "Swedesboro", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90403", "recalling_firm": "Wedgewood Village Pharmacy, LLC", "address_1": "405 Heron Dr Ste 200", "address_2": "N/A", "postal_code": "08085-1749", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Products were distributed nationwide in the USA.", "recall_number": "D-1182-2022", "product_description": "Doxycycline (as Calcium) (equivalent to 50mg/5mL), 10 mg/ml, 60 ml suspension bottles, Peppermint, Qty: 1, Wedgewood Village Pharmacy LLC, 405 Heron Dr, Ste 200, Swedesboro, NJ 08085", "product_quantity": "24 bottles", "reason_for_recall": "Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection", "recall_initiation_date": "20220610", "center_classification_date": "20220707", "termination_date": "20230216", "report_date": "20220713", "code_info": "Lot#: 000-03852523, Exp Date: 09/01/22; Lot#: 000-03766625, Exp Date:07/10/22;  Lot#: 000-03780127, Exp Date: 08/6/22;  Lot#: 000-03794760, Exp Date: 08/6/22;   Lot#: 000-03892723, Exp Date: 09/1/22;   Lot#: 000-03641022, Exp Date: 06/17/22;   Lot#: 000-03693714, Exp Date: 06/28/22;   Lot#: 000-03770510, Exp Date: 08/6/22;   Lot#: 000-03852462, Exp Date: 09/1/22;  Lot#: 000-03840601, Exp Date: 09/1/22;   Lot#: 000-03706934, Exp Date: 06/28/22;  Lot#: 000-03850609, Exp Date: 09/1/22;  Lot#: 000-03650269, Exp Date: 06/17/22; Lot#: 000-03870004, Exp Date: 09/1/22;   Lot#: 000-03693748, Exp Date: 06/28/22;   Lot#: 000-03904403, Exp Date: 09/1/22;  Lot#: 000-03799564, Exp Date: 08/06/22;   Lot#: 000-03723022, Exp Date: 06/28/22;   Lot#: 000-03872892, Exp Date: 09/01/22;  Lot#: 000-03885204, Exp Date: 09/01/22;  Lot#: 000-03848586, Exp Date: 09/01/22; Lot#: 000-03903599, Exp Date: 09/01/22; Lot#: 000-03812001, Exp Date: 08/06/22;", "more_code_info": ""}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0268-2016", "product_description": "MIC Combo (Methionine 25 mg/mL, Inositol 50 mg/mL, Choline chloride 50 mg/mL, Cyanocobalamin 1000 mcg/mL), 30 mL Multi-Dose Vial, For Deep IM Injection Only, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3127-06.", "product_quantity": "1,939 vials", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot Numbers: 20150705@32 BUD: 11/2/2015, 20151304@17 BUD: 10/10/2015, 20151905@56 BUD: 11/15/2015, 20152004@9 BUD: 10/17/2015"}, {"status": "Ongoing", "city": "Tesuque", "state": "NM", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92952", "recalling_firm": "Dr. Berne's Whole Health Products", "address_1": "174 Tesuque Village Rd Unit 458", "address_2": "N/A", "postal_code": "87574-2030", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and UK, Canada, Italy, India, Australia, Germany, Switzerland, Singapore, Netherlands, Ireland, South Korea, Belgium, Norway, Saudi- Arabia, Slovenia, Malta, Israel, Sweden, Latvia, Portugal, Hong Kong, Kuwait, Romania, South Africa, Thailand, Zambia, France, Finland, Mauritius, Barbados.", "recall_number": "D-0036-2024", "product_description": "Dr. Berne's MSM DROPS 5% Solution, 30 mL/1.014 OZ bottle, Distributed by: Dr. Berne's Whole Health Products, Tesuque, NM, 87574, hello@drsamberne.com, UPC 00854582001111.", "product_quantity": "3833 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20230826", "center_classification_date": "20231004", "report_date": "20231011", "code_info": "Lot: 6485, Exp: 11/23: 6562, Exp: 03/24; 6624, Exp: 06/24; 6669, Exp: 08/24; 6688, Exp: 09/24; 6727, EXP: 11/24; 6771, Exp: 02/25; 6830, Exp: 03/25; 6887, Exp: 07/25."}, {"status": "Terminated", "city": "Huntsville", "state": "AL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "72493", "recalling_firm": "Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals", "address_1": "150 Vintage Dr NE", "address_2": "N/A", "postal_code": "35811-8216", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0162-2016", "product_description": "RANITIDINE SYRUP (RANITIDINE ORAL SOLUTION, USP) 15 mg/mL (75 mg/5 mL), 473 mL (16 fl oz), Rx only. Manufactured for:  QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC: 0603-9418-58.", "product_quantity": "61,146 Bottles", "reason_for_recall": "Failed Stability Specifications: Out of Specification results obtained for preservative butylparaben.", "recall_initiation_date": "20151021", "center_classification_date": "20151102", "termination_date": "20161023", "report_date": "20151111", "code_info": "Lot #: L088L13A, Expiry: 12/15; Lot #: L023F14A, Expiry: 5/16; Lot#: L024F14A, Expiry: 5/16."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92898", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1126-2023", "product_description": "PHENYLephrine added to 0.9% sodium chloride, 20mg/250ml (80 mcg/mL), IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-7025-1.", "product_quantity": "297 bags", "reason_for_recall": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles", "recall_initiation_date": "20230817", "center_classification_date": "20230828", "termination_date": "20250327", "report_date": "20230906", "code_info": "Lot# 36-260037, Exp 10/3/2023.              ;"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70743", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W. Field Court, Suite 300", "address_2": "N/A", "postal_code": "60045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0997-2015", "product_description": "SULFAMETHOXAZOLE AND TRIMETHOPRIM ORAL SUSPENSION, USP 800 mg/ 160 mg per 5mL, GRAPE FLAVOR, 20 mL unit dose cup (NDC 50383-0824-20), Rx only, HI-TECH PHARMACAL CO. INC, Amityville, NY 11701", "product_quantity": "8,400 unit dose cups (20 mL each)", "reason_for_recall": "Failed Dissolution Specifications: Out of specification for dissolution of sulfamethoxazole.", "recall_initiation_date": "20150317", "center_classification_date": "20150508", "termination_date": "20171227", "report_date": "20150520", "code_info": "Lot # 624271, Exp. Date 10/2015", "more_code_info": ""}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-257-2014", "product_description": "Post-menopausal HCG Pk 2nd mont, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "80 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210221"], "brand_name": ["CEPHALEXIN"], "generic_name": ["CEPHALEXIN"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-544", "67877-545"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEPHALEXIN"], "rxcui": ["309110", "309113"], "spl_id": ["84f07b4a-a15e-41cb-af85-e110c5cf342e"], "spl_set_id": ["bb28751c-bd1b-4e7f-8271-a14c1b4314e3"], "package_ndc": ["67877-544-88", "67877-544-68", "67877-545-88", "67877-545-68"], "is_original_packager": [true], "unii": ["OBN7UDS42Y"]}, "product_type": "Drugs", "event_id": "87214", "recalling_firm": "Ascend Laboratories LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0264-2021", "product_description": "Cephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when mixed) Rx Only, Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-68", "product_quantity": "23,436 200 mL bottles", "reason_for_recall": "CGMP Deviations: Individual Unidentified impurities results of the product was found at higher side of the specification limit.", "recall_initiation_date": "20210122", "center_classification_date": "20210218", "termination_date": "20221202", "report_date": "20210224", "code_info": "Lot #: 19141869, 19141870, EXP 3/2021; 19142762, EXP 5/2021; 19143826, 19143923,19143941, 19143954 EXP 7/2021"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: PERPHENAZINE, Tablet, 16 mg may have potentially been mislabeled as one of the following drugs:  LITHIUM CARBONATE ER, Tablet, 450 mg, NDC 00054002025, Pedigree: AD21790_28, EXP: 5/1/2014;  LITHIUM CARBONATE ER, Tablet, 450 mg, NDC 00054002025, Pedigree: W002730, EXP: 6/6/2014;  RALTEGRAVIR, Tablet, 400 mg, NDC 00006022761, Pedigree: W003680, EXP: 6/25/2014;  VENLAFAXINE HCL", "address_2": "", "product_quantity": "1200 Tablets", "code_info": "PERPHENAZINE, Tablet, 16 mg has the following codes:   Pedigree: AD21790_31, EXP: 5/1/2014;  Pedigree: W002731, EXP: 6/6/2014;  Pedigree: W003682, EXP: 6/25/2014;  Pedigree: AD73525_22, EXP: 5/30/2014;  Pedigree: W003328, EXP: 6/19/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PERPHENAZINE, Tablet, 16 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781104901.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-998-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1377-2022", "product_description": "DIAL MENS EUCALYPTUS AB BODY WASH 20 FLOZ SKU 2096030 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKU: 2096030", "more_code_info": ""}, {"status": "Terminated", "city": "Venice", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87828", "recalling_firm": "Scentsational Soaps & Candles Inc", "address_1": "730 Commerce Dr", "address_2": "N/A", "postal_code": "34292-1726", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0672-2021", "product_description": "Goose Creek Hand Sanitizer aloe Blueberry Limeade, Anti-Bacterial Spray, 3.38 FL. OZ. (100 mL), Goose Creek www.GooseCreekCandle.com, 1498 S. Wallace Wilkinson Blvd. Liberty, KY 42539, UPC 8 14630 02049 5", "product_quantity": "1,296 bottles", "reason_for_recall": "Chemical contamination: product found to be contaminated with methanol (wood alcohol), benzene and acetaldehyde.", "recall_initiation_date": "20210427", "center_classification_date": "20210719", "termination_date": "20221202", "report_date": "20210728", "code_info": "Lot #: 20258", "more_code_info": ""}, {"status": "Terminated", "city": "Highland", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89334", "recalling_firm": "ULTRAtab Laboratories, Inc.", "address_1": "50 Toc Dr", "address_2": "N/A", "postal_code": "12528-1506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Bulk product was distributed to 3 distributors who may have distributed finished product.", "recall_number": "D-0553-2022", "product_description": "Coated Back Relief Tablet (Acetaminophen 250 mg, Magnesium Salicylate 290 mg, Caffeine 50 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY  NDC 62959-800-00", "product_quantity": "25,769,495 tablets", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20220126", "center_classification_date": "20220209", "termination_date": "20250107", "report_date": "20220216", "code_info": "Product Codes: M800L  Bulk Lots: 18K005, 18K075, 18K098, 18M064, 19C021, 19C050, 19G081, 19G082, 19H012, 19H013, 19J036, 19J037"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-517-2015", "product_description": "Amlodipine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Brockton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090982"], "brand_name": ["FLUOCINOLONE ACETONIDE"], "generic_name": ["FLUOCINOLONE ACETONIDE"], "manufacturer_name": ["RISING PHARMA HOLDINGS, INC."], "product_ndc": ["64980-330"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["FLUOCINOLONE ACETONIDE"], "rxcui": ["1191307"], "spl_id": ["e5106a37-a35c-482d-96de-2f5a47abee1e"], "spl_set_id": ["f4a58ecc-cd50-4414-add1-a82b09da2058"], "package_ndc": ["64980-330-04", "3649803300"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["0CD5FD6S2M"], "upc": ["364980330046"]}, "product_type": "Drugs", "event_id": "79860", "recalling_firm": "Lyne Laboratories, Inc.", "address_1": "10 Burke Dr", "address_2": "N/A", "postal_code": "02301-5505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "to be entered", "recall_number": "D-0713-2018", "product_description": "Fluocinolone Acetonide Topical Oil, 0.01% (Scalp Oil) 118.28 mL (4 fl.oz.) Rx Only, Manufactured by: Lyne Laboratories, Inc. Brockton, MA 02307 Manufactured for: Rising Pharmaceuticals, Inc. Allendale, NJ 07401, NDC 64980-330-04, UPC 364980330046", "product_quantity": "23453 units", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20180413", "center_classification_date": "20180504", "termination_date": "20190516", "report_date": "20180502", "code_info": "Lot #: FR1601, FR1602, Exp. 05/2018"}, {"status": "Terminated", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77634", "recalling_firm": "PharMedium Services, Llc", "address_1": "12620 W Airport Blvd Ste 130", "address_2": "N/A", "postal_code": "77478-6200", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0995-2017", "product_description": "Potassium PHOSphate in 5% Dextrose Injection, 9 mMol in 50 mL in 50 mL Intravia Bag, Rx Only, PharMEDium Services, LLC 12620 W. Airport Blvd #130 Sugar Land, TX 77478 800-523-7749 Service Code 2K5310 NDC# 61553-310-41", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; media fill failure at manufacturer", "recall_initiation_date": "20170626", "center_classification_date": "20170714", "termination_date": "20200429", "report_date": "20170726", "code_info": "Lots: 171160002S Exp. 7/26/2017, 171560007S Exp. 9/4/2017"}, {"status": "Terminated", "city": "Sterling", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91443", "recalling_firm": "Northern VA Compounders PLLC", "address_1": "23475 Rock Haven Way", "address_2": "Suite 105", "postal_code": "20166-4444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0102-2023", "product_description": "Mitomycin Injection Solution, 4mg/ml, packaged in a 10 mL Multiple-Dose vial, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA  20166.", "product_quantity": "2 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20221230", "center_classification_date": "20230112", "termination_date": "20230621", "report_date": "20230118", "code_info": "Lot#: 12062022@7, Exp 1/20/2023; 12072022@32, Exp 1/22/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Chester Springs", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86069", "recalling_firm": "Vilvet Pharmaceuticals Inc.", "address_1": "1208 Kimberton Rd Ste 101", "address_2": "", "postal_code": "19425-1437", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the US", "recall_number": "D-1488-2020", "product_description": "VILEVEV MB Urinary Antispetic (81.0 mg methenamine, 40.8 mg sodium phosphate monobasic and 10.8 mg methylene blue, 0.12 mg hyoscyamine sulfate and 32.4 mg phenyl salicylate), Rx Only, 90 Tablets per Bottle, Manufactured for: Vilvet Pharmaceuticals, Inc., Chester Springs, PA 19425, NDC 71186-000-24.", "product_quantity": "1,716 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20200724", "center_classification_date": "20200806", "termination_date": "20220121", "report_date": "20200812", "code_info": "LOT M823J18-1, M823J18-2, M823J18-3 EXP 09/20;  LOT M823D19-1 EXP 04/21", "more_code_info": ""}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1757-2019", "product_description": "CARFILZOMIB 65 MG IN 50 ML D5W IVPB; CARFILZOMIB 75 MG IN 50 ML D5W IVPB; CARFILZOMIB 50 MG IN 50 ML D5W IVPB; CARFILZOMIB 45 MG IN 50 ML D5W IVPB; CARFILZOMIB 46.2 MG IN 50 ML D5W IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090778"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["57237-017", "57237-018", "57237-019"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934"], "spl_id": ["4166006e-ead3-4e01-8b11-07d26ac957ed"], "spl_set_id": ["ea2dc1a6-22d5-4295-9d39-9bf015dc5a89"], "package_ndc": ["57237-017-60", "57237-017-99", "57237-018-30", "57237-018-90", "57237-018-99", "57237-019-30", "57237-019-90", "57237-019-99"], "is_original_packager": [true], "upc": ["0357237018309", "0357237017609", "0357237019306"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96074", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0188-2025", "product_description": "Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000 count (NDC 57237-018-99) bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ", "product_quantity": "42,527 bottles", "reason_for_recall": "CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.", "recall_initiation_date": "20241230", "center_classification_date": "20250108", "report_date": "20250115", "code_info": "a) Lot# DT3023051A, exp. date Apr-25;  b) DT3023025A, exp. date Jan-25", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92898", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1125-2023", "product_description": "PHENYLephrine, added to 0.9% sodium chloride, 10mg/250ml (40mcg/mL), IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043,  NDC: 72196-6058-1.", "product_quantity": "586 bags", "reason_for_recall": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles", "recall_initiation_date": "20230817", "center_classification_date": "20230828", "termination_date": "20250327", "report_date": "20230906", "code_info": "Lot# 36-260034, 36-260033, Exp 10/3/2023.              ;"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77777", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1003-2017", "product_description": "MAGNESIUM Sulfate 4 g added to 100 mL 0.9% Sodium Chloride, Total Approximate Volume 108 mL (does not include mfg. overfill) Single Dose Container bag, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct, Little Rock, AR 72205 (877) 550-5059; NDC: 70004-0737-32.", "product_quantity": "40 bags", "reason_for_recall": "Lack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.", "recall_initiation_date": "20170714", "center_classification_date": "20170725", "termination_date": "20191030", "report_date": "20170802", "code_info": "Lot: 20170710@54, BUD: 10/8/2017"}, {"status": "Terminated", "city": "Tulsa", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71618", "recalling_firm": "The Apothecary Shoppe LLC", "address_1": "6136 E 51st St", "address_2": "N/A", "postal_code": "74135-7704", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Oklahoma", "recall_number": "D-1299-2015", "product_description": "SIU-Papav/Phentol 30/.5 mg/mL Injection, Rx Only, 3 mL Vial, Apothecary Shoppe, Compounding Pharmacy, Tulsa OK 74135,  NDC 99999-1775-01", "product_quantity": "2.5 mL", "reason_for_recall": "Lack of Assurance of Sterility: Due to lack of documentation of proper environmental monitoring during the time in which the medication was produced.", "recall_initiation_date": "20150626", "center_classification_date": "20150806", "termination_date": "20170217", "report_date": "20150812", "code_info": "Lot #: 04082015@37, BUD 10/05/2015"}, {"status": "Ongoing", "city": "Millburn", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95420", "recalling_firm": "Advanced Accelerator Applications USA, Inc.", "address_1": "57 E Willow St", "address_2": "N/A", "postal_code": "07041-1416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MA, NJ, NY, PA, and VA", "recall_number": "D-0007-2025", "product_description": "Pluvicto, 1000 MBq/mL (27 mCi/mL), lutetium, LU 177, vipivotide tetraxetan injection, Single-dose vial, Sterile, Manufacturer Advanced Accelerator Applications,  57 E. Willow Street, NJ 07041, Millburn USA. NDC 69488-0010-61", "product_quantity": "99 doses", "reason_for_recall": "CGMP deviations", "recall_initiation_date": "20240923", "center_classification_date": "20241003", "report_date": "20241009", "code_info": "Lot#: LPS240919B-16, 24-Sep-2024 Lot#: LPS240920B-16, 25-Sep-2024  Lot#: LPS240920C-16, 25-Sep-2024"}, {"status": "Terminated", "city": "West Deptford", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83457", "recalling_firm": "Johnson Matthey Inc.", "address_1": "2003 Nolte Dr", "address_2": "", "postal_code": "08066-1727", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1880-2019", "product_description": "Fentanyl Citrate Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ 08066-1742 (856) 384-7001.", "product_quantity": "52882.23 grams", "reason_for_recall": "cGMP Deviations: Potential glass contamination", "recall_initiation_date": "20190829", "center_classification_date": "20190925", "termination_date": "20220121", "report_date": "20191002", "code_info": "Lot #: B0030-180101, B0030-180102, Exp. Feb 2023", "more_code_info": ""}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1660-2019", "product_description": "FOLIC ACID 10MG/ML INJECTION SOLUTION (MDV), 5 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0921-05", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Middletown", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80053", "recalling_firm": "RIJ Pharmaceutical LLC", "address_1": "40 Commercial Ave", "address_2": "N/A", "postal_code": "10941-1444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0846-2018", "product_description": "Gericare Liquid Pain Relief Acetaminophen Cherry Flavor 160mg/5mL, packaged in 16 FL OZ (473 mL), Dist. By Gericare Pharmaceuticals 1650 63rd Street Brooklyn, NY 11204, NDC 5789618016, UPC 357896180164", "product_quantity": "13380 bottles", "reason_for_recall": "CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.", "recall_initiation_date": "20180507", "center_classification_date": "20180608", "termination_date": "20230407", "report_date": "20180620", "code_info": "Lot #: 47080081, 47080093, Exp. 08/19"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77725", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0984-2017", "product_description": "Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg 30 tablets per Bottle, Rx only, Distributed By: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5721-56", "product_quantity": "196275 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:  out of specification test results for related compounds largest unknown impurity.", "recall_initiation_date": "20170629", "center_classification_date": "20170714", "termination_date": "20180426", "report_date": "20170726", "code_info": "Lot #: 30227649A ,30227650A, 30227651A, 30227652A, 30227653A, 30227654A, 30227655A, 30227832A,  30227833A, 30227834A, 30227835A, EXP 06/2017; 30228561A, 30228562A, 30228563A,  30228564A, 30228565A, 30228566A, 30228567A, 30228568A, 30228569A, 30228570A, EXP 9/2017;  3000124, 3000125,  EXP 7/2018; 3000392, 3000393, 3000394, EXP 9/2018; 3000872, 3000874, EXP 10/2018;"}, {"status": "Terminated", "city": "Romeoville", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "69611", "recalling_firm": "Nanophase Technologies Corporation", "address_1": "1319 Marquette Dr", "address_2": "N/A", "postal_code": "60446-4055", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "NJ", "recall_number": "D-0238-2015", "product_description": "Z-COTE HP 1 TRANSPARENT ZINC OXIDE, Zinc Oxide (and) Triethoxycaprylylsilane, Powder, NET: 22 KG, Packaged in double plastic liners in a single fiber carton, FOR MANUFACTURING, PROCESSING OR REPACKING, BASF Corporation, Florham Park, NJ", "product_quantity": "1,596 Kg", "reason_for_recall": "cGMP Deviation; The incorrect amount of a raw material was added during the manufacture of two lots of Z-COTE HP 1.", "recall_initiation_date": "20141020", "center_classification_date": "20141106", "termination_date": "20150611", "report_date": "20141112", "code_info": "Lot Codes: CNNI2901, CNNI2902"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0352-2017", "product_description": "Chorionic Gonadotropin+B12(C), Lyophilized, 10,000 unit + 40 mcg Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "724 kits (number of vials per kit vary by prescription)", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known kit lot code: 05042016@162, 06062016@122, 08192016@110.  Known vial lot code: 04252016@168, 05252016@117, 08152016@40."}, {"status": "Terminated", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85507", "recalling_firm": "B. Braun Medical Inc", "address_1": "2525 Mcgaw Ave", "address_2": "N/A", "postal_code": "92614-5841", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide within the United States.", "recall_number": "D-1257-2020", "product_description": "Ceftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex Container, RX only, B Braun Medical Inc., Bethlehem, PA 18018-3524, NDC 0264-3145-11", "product_quantity": "22,488 Duplex containers", "reason_for_recall": "Failed Stability Specifications: Out-of-Specification (OOS) results for High Molecular Weight Polymers.", "recall_initiation_date": "20200418", "center_classification_date": "20200428", "termination_date": "20211021", "report_date": "20200506", "code_info": "Lot #: H8J812, Exp. Date 31 JUL 2020"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-891-2015", "product_description": "Sertraline HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1396 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Completed", "city": "Jenison", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85854", "recalling_firm": "MICHIGAN HERBAL REMEDIES", "address_1": "904 Chicago Dr", "address_2": "", "postal_code": "49428-9351", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide via internet sales,retailers and distributors in the USA", "recall_number": "D-1478-2020", "product_description": "BC Hemp Co., Full Spectrum Hemp Extract, CBD Oil , Berry Blast, 1000MG CBD, 1 FL. OZ (30ML) bottles, Distributed by: B.C. Hemp Co., LLC, P.O. Box 156, Eau Claire, MI 49111", "product_quantity": "50 bottles", "reason_for_recall": "Chemical contamination: product contains elevated levels of undeclared lead.", "recall_initiation_date": "20200618", "center_classification_date": "20200804", "report_date": "20200812", "code_info": "FG003164", "more_code_info": ""}, {"status": "Terminated", "city": "Bensalem", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200295"], "brand_name": ["LIOTHYRONINE SODIUM"], "generic_name": ["LIOTHYRONINE SODIUM"], "manufacturer_name": ["SIGMAPHARM LABORATORIES, LLC"], "product_ndc": ["42794-018", "42794-019", "42794-020"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LIOTHYRONINE SODIUM"], "rxcui": ["903456", "903697", "903703"], "spl_id": ["f1f181e3-ceed-1d17-e053-2995a90af5cd"], "spl_set_id": ["38ef3766-bb9a-402e-9e4a-ad8bb5b26e4c"], "package_ndc": ["42794-018-02", "42794-018-12", "42794-018-06", "42794-019-02", "42794-019-06", "42794-019-12", "42794-020-02", "42794-020-12"], "is_original_packager": [true], "upc": ["0342794018121", "0342794019128", "0342794020124"], "unii": ["GCA9VV7D2N"]}, "product_type": "Drugs", "event_id": "68123", "recalling_firm": "SigmaPharm Laboratories LLC", "address_1": "3375 Progress Dr", "address_2": "N/A", "postal_code": "19020-5801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1344-2014", "product_description": "Liothyronine Sodium Tablets, USP 5 mcg, Rx Only, a) 100-count bottle NDC 42794-018-02 and b) 1000-count bottle NDC 42794-018-06, SigmaPharm Laboratories, LLC, Bensalem, Pa.", "product_quantity": "43,007 Bottles", "reason_for_recall": "Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a potential carryover of trace amounts of a previously manufactured product.", "recall_initiation_date": "20140422", "center_classification_date": "20140521", "termination_date": "20150316", "report_date": "20140528", "code_info": "Lot #s: a) 1302201, Exp 01/2015; 1305501, Exp 03/2015; 1314801, Exp 10/2015; b) 1302202, Exp 01/2015"}, {"status": "Terminated", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66607", "recalling_firm": "Mylan Institutional, Inc. (d.b.a. UDL Laboratories)", "address_1": "1718 Northrock Ct", "address_2": "N/A", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-0377-2015", "product_description": "CIPROFLOXACIN TABLETS, USP, 500 mg, 100 Tablets (10 tablets per blister card. 10 blister cards per carton), Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV --- NDC 51079-182-20.", "product_quantity": "11,650 cartons", "reason_for_recall": "CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices", "recall_initiation_date": "20130926", "center_classification_date": "20150121", "termination_date": "20151109", "report_date": "20150128", "code_info": "Lot Number: 3034630;   Expiration Date: 12/13;   NDC: 51079-182-20"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81344", "recalling_firm": "Bound Tree Medical, LLC", "address_1": "1420 Lakeside Parkway", "address_2": "N/A", "postal_code": "75208", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0384-2019", "product_description": "curaplex Epi Safe Kit, 8600-01101,  contains:\" 1ml Vial of Epinephrine \" 1 Epi-Safe Syringe \" 1 Safety Needle \" 2 Alcohol Prep Pads \" 1 Adhesive Dressing \" 1 Insert, Rx Only. Distributed by Sarnova HC, LLC s family of companies: Bound Tree Medical, LLC, Cardio Partners, Inc., Emergency Medical Products, Inc. &  Tri-anim Health Services, Inc. 5000 Tuttle Crossing Blvd. Dublin, OH 43016", "product_quantity": "7,063 kits (1 syringe per kit / 1 IFU per kit)", "reason_for_recall": "Labeling Incorrect Instructions:  This recall has been initiated because the Instructions for Use included in the Epi-Safe Kits for the Epi-Safe Syringe (and/or the Safety Lok Syringe in Model 8600-01120) recommend a midpoint dosage of epinephrine for children between 0 lbs. and 66 lbs. of 0.15mL that has not been approved by FDA for children. Reliance on the current IFU and/or use of the Epi-Safe Syringe as instructed may result in the administration of an inappropriate dosage of epinephrine to young children experiencing anaphylaxis, especially those under 33 lbs. Additionally the Epi Safe syringe does not have the correct markings to allow a health care provider to draw up the correct dosage for children under 33 kg.", "recall_initiation_date": "20181102", "center_classification_date": "20190118", "termination_date": "20200605", "report_date": "20190130", "code_info": "all lot numbers"}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {"application_number": ["M018"], "brand_name": ["EYES IRRITATION RELIEF"], "generic_name": ["POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE"], "manufacturer_name": ["CARDINAL HEALTH 110, LLC. DBA LEADER"], "product_ndc": ["70000-0087"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["POLYVINYL ALCOHOL, UNSPECIFIED", "POVIDONE, UNSPECIFIED", "TETRAHYDROZOLINE HYDROCHLORIDE"], "rxcui": ["1235569"], "spl_id": ["aaaabf8c-8ca5-4fe3-8e21-ba270c7f3991"], "spl_set_id": ["bd2608c6-ffdf-352a-e053-2995a90a26a8"], "package_ndc": ["70000-0087-1"], "is_original_packager": [true], "unii": ["532B59J990", "FZ989GH94E", "0YZT43HS7D"]}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0297-2024", "product_description": "Leader brand Eye Irritation Relief (Polyvinyl alcohol 0.5%, Povidone 0.6%, Tetrahydrozoline 0.05%), packaged in 0.5 FL OZ (15 mL) bottles, Cardinal Health Dublin, Ohio 43017, NDC 70000-0087-1", "product_quantity": "10,944 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Weeki Wachee", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83146", "recalling_firm": "Premier Pharmacy Labs Inc", "address_1": "8265 Commercial Way", "address_2": "N/A", "postal_code": "34613-4511", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1411-2019", "product_description": "Atropine Sulfate PF INJ, 0.8 mg/2 mL (0.4 mg/mL), 2mL Single Dose Syringe, Rx only, Premier Pharmacy Labs, 8265 Commercial Way, Weeki Wachee, FL 34613, NDC: 69623-131-12, barcode 0 69623 13112 6.", "product_quantity": "745 syringes", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.", "recall_initiation_date": "20190618", "center_classification_date": "20190621", "termination_date": "20211026", "report_date": "20190703", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Henderson", "state": "NV", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80343", "recalling_firm": "Gaia Ethnobotanical LLC", "address_1": "2752 Botticelli Dr", "address_2": "", "postal_code": "89052-3107", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-0999-2018", "product_description": "Gaia Kratom (mitragyna speciosa) powder, Green Malay, 1oz, 250g, 1kg packages, Gaia Ethnobotanical.com", "product_quantity": "unknown", "reason_for_recall": "Microbal Contamination of Non-Sterile Product; FDA analysis found  salmonella contamination", "recall_initiation_date": "20180620", "center_classification_date": "20180726", "termination_date": "20220126", "report_date": "20180718", "code_info": "Lot # 0102031800, exp", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0200-2021", "product_description": "Lidocaine HCl 2% 5 mL, 20 mg/mL, Rx Only, 5 mL syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004072309", "product_quantity": "7,275 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023034, BUD 1/19/2021;  1220023088, BUD 1/24/2021; 1220023112, BUD 1/25/2021;  1220023288, BUD 1/31/2021; 1220023323, BUD 2/2/2021;  1220023539, BUD 2/8/2021 &  1220023613, BUD 2/10/2021.", "more_code_info": ""}, {"country": "United States", "city": "Dallas", "address_1": "4001 McEwen Rd Suite 110", "reason_for_recall": "Lack of Assurance of Sterility: The recall is being initiated due to a lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection.", "address_2": "", "product_quantity": "285 vials", "code_info": "Lot #s:  N06252012@6 Exp 6/25/13; N01042013@15 Exp 1/29/14; N05072012@3 Exp 2/1/15", "center_classification_date": "20140130", "distribution_pattern": "Nationwide", "state": "TX", "product_description": "HCG (Lyophilized) Stock # 21714, 5000 IUnits-5 mL vial, Compounded by NuVision Pharmacy Dallas, TX 75244", "report_date": "20140205", "classification": "Class I", "openfda": {}, "recalling_firm": "NuVision Pharmacy, Inc.", "recall_number": "D-1051-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64922", "termination_date": "20170208", "more_code_info": "", "recall_initiation_date": "20130415", "postal_code": "75244-5020", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Trujillo Alto", "state": "PR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91325", "recalling_firm": "Frenda Corporation", "address_1": "Calle A Lote 7 Parque Ind Las Cuevas", "address_2": "N/A", "postal_code": "00976", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Puerto Rico", "recall_number": "D-0259-2023", "product_description": "Global Care Antibacterial Hand Sanitizer Alcohol Etilico 70% Original, 1 Gallon (128 FL OZ) 3785.41 mL, Dist. by Target Price, Inc. Catano, PR, UPC 8 70373 01326 2", "product_quantity": "124 bottles", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20221215", "center_classification_date": "20230130", "termination_date": "20240910", "report_date": "20230208", "code_info": "Lot: C013121"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0610-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Grief & Guilt Reliever, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955503828, NDC 57955-5038-2", "product_quantity": "400 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 022417G Exp. 02/20; 052516N Exp. 05/19; 080416D Exp. 08/19"}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89543", "recalling_firm": "Junp Hydration LLC", "address_1": "1013 Mcdonald Ave", "address_2": "N/A", "postal_code": "11230-1009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed nationwide in the USA via Amazon Marketplace", "recall_number": "D-0557-2022", "product_description": "MegMan Performance Booster, 800 mg capsules, packaged in 10-count blisters packaged in a carton, UPC 8 48998 00091 2, ASIN B08Z74KS88", "product_quantity": "750 cartons", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.", "recall_initiation_date": "20220204", "center_classification_date": "20220211", "termination_date": "20220609", "report_date": "20220216", "code_info": "Lot # 2010291, Exp 01/07/2024"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "85357", "recalling_firm": "Noven Therapeutics, LLC", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the US", "recall_number": "D-1249-2020", "product_description": "Daytrana (methylphenidate transdermal system) Delivers 30 mg over 9 hours (3.3 mg/hr) 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC Miami, FL 33186, NDC 68968-5555-3", "product_quantity": "14,142 30-count boxes", "reason_for_recall": "Defective Delivery System: Out of specification for mechanical peel and shear.", "recall_initiation_date": "20200331", "center_classification_date": "20200417", "termination_date": "20240617", "report_date": "20200429", "code_info": "Lots: 86355 Exp. 07/2020; 86356 Exp.08/2020; 86550 Exp. 07/2020; 87348 Exp. 01/2021; 87965 Exp. 01/2021"}, {"status": "Terminated", "city": "Hendersonville", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83997", "recalling_firm": "Basic Reset Inc.", "address_1": "260 W Main St Ste 103", "address_2": "N/A", "postal_code": "37075-7316", "voluntary_mandated": "FDA Mandated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and U.S. Virgin Islands, Canada, Nigeria, United Kingdom, Australia, Israel, Hungary, UAE, Mexico, Philippines, Greece", "recall_number": "D-0193-2020", "product_description": "Basic Reset CBD Reset 750 True Full Spectrum Natural Flavor 750 mg CBD 1 fl. oz. (30 mL) bottle, Distributed by: Basic Reset Hendersonville, TN 37075", "product_quantity": "98 bottles", "reason_for_recall": "Marketed without an Approved NDA/ANDA", "recall_initiation_date": "20191018", "center_classification_date": "20191105", "termination_date": "20211027", "report_date": "20191113", "code_info": "Lot: 1916911.25"}, {"status": "Terminated", "city": "Pine Level", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62775", "recalling_firm": "Custom Medical Specialties, Inc.", "address_1": "330 East Main Street", "address_2": "N/A", "postal_code": "27568", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "FAX", "distribution_pattern": "GA, MD, MA", "recall_number": "D-1650-2012", "product_description": "CMS-8934 Custom Phlebectomy Tray, Sterile, contains Sodium chloride 0.9% 50 mL, Manufactured by: CMS, Custom Medical Specialties, Inc., 330 East Main St, PO Box 177, Pine level, NC 27568, the tray also contains other components not listed in this product description.", "product_quantity": "20 Trays", "reason_for_recall": "Lack of Assurance of Sterility; the firm's medical trays contain Hospira's 0.9% Sodium Chloride bags which were subject to recall due to leaking bags.", "recall_initiation_date": "20120723", "center_classification_date": "20120817", "termination_date": "20121011", "report_date": "20120829", "code_info": "Lot #: 25915-1111, Exp 12/2012"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-502-2015", "product_description": "Adapalene active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "25 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1187-2020", "product_description": "Bi-Est (8:2) Progest/Test 2/80/3 mg/mL cream 30 gm tube, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 tube", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45098 Discard by: 8/16/2020", "more_code_info": ""}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0292-2017", "product_description": "Sermorelin Forte Plus 18 mg (Sermorelin Acetate 6 mg/GHRP-6 6 mg/GHRP-2 6 mg).  Compounded by Tri-Coast Pharmacy", "product_quantity": "441 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 05252016C (11/21/2016), 07252016B (01/21/2017), 09192016B (03/18/2016)."}, {"status": "Terminated", "city": "Oklahoma City", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92081", "recalling_firm": "PD-Rx Pharmaceuticals, Inc.", "address_1": "727 N Ann Arbor Ave", "address_2": "", "postal_code": "73127-5822", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US.", "recall_number": "D-0558-2023", "product_description": "Simvastatin USP, 10 mg, Rx only, Intas Pharm, Limited Ahmedabad 380 054 India Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 a) 30 count-bottle (NDC 43063-0727-30) b) 90 count-bottle (NDC 43063-0727-90)", "product_quantity": "37 bottles", "reason_for_recall": "CGMP deviations.", "recall_initiation_date": "20230406", "center_classification_date": "20230501", "termination_date": "20240430", "report_date": "20230510", "code_info": "Lots: a) K22E32 Exp. 10/31/23; b) H22C33 Exp. 09/30/23; H22C81, J22C83, K22E36 Exp. 10/31/23", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70118", "recalling_firm": "Walgreens Infusion Services", "address_1": "9030 Kirby Dr", "address_2": "N/A", "postal_code": "77054-2504", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas, Florida, Virginia, Georgia, Louisiana, Mississippi", "recall_number": "D-0367-2015", "product_description": "Thiamine 100 mg/ ml vials", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20141226", "center_classification_date": "20150116", "termination_date": "20150724", "report_date": "20150128", "code_info": "All products within expiry."}, {"country": "United States", "city": "Lake Forest", "address_1": "150 N Field Dr Ste 350", "reason_for_recall": "Lack of Assurance of Sterility: A portion of the batch quantity was compounded outside of the firm's process media validation.", "address_2": "", "product_quantity": "1550 units", "code_info": "Lot #: 162790012M, Exp. 1/3/2017", "center_classification_date": "20161103", "distribution_pattern": "Nationwide", "state": "IL", "product_description": "Succinylcholine Chloride, 20 mg per mL, 200 mg per 10 mL, 10 mL vials, Rx only, PharMEDium Services, LLC, Memphis, TN, NDC 61553-0364-65.", "report_date": "20161109", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmedium Services, LLC", "recall_number": "D-0125-2017", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "75567", "termination_date": "20161108", "more_code_info": "", "recall_initiation_date": "20161012", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Charlotte", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82620", "recalling_firm": "CMC Enterprise Pharmacy", "address_1": "4400 Golf Acres Dr", "address_2": "N/A", "postal_code": "28208-5968", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NC", "recall_number": "D-1219-2019", "product_description": "Oxytocin 30 units in NS 500 mL bag, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.", "product_quantity": "3690 bags", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190412", "center_classification_date": "20190423", "termination_date": "20191030", "report_date": "20190501", "code_info": "Lots: EA241909 Exp. 4/24/2019; EA281909 Exp. 4/28/2019; EA301910 Exp. 4/30/2019; EB111909 Exp. 5/12/2019; EB141909 Exp. 5/15/2019; EB221908 Exp. 5/23/2019; EC061908 Exp. 6/4/2019; EC131909 Exp. 6/11/2019; EC261910 Exp. 6/24/2019"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0721-2020", "product_description": "CLON 100MCG/MORP 12MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@24 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Vernon Hills", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78369", "recalling_firm": "Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company", "address_1": "330 Corporate Woods Pkwy", "address_2": "N/A", "postal_code": "60061-3107", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "IA, WI", "recall_number": "D-0160-2018", "product_description": "Sterile Eyewash (sterile isotonic phosphate buffered saline solution), 32 oz. 12 units per box. Manufactured by Medex Cardio-Pulmonary Inc. d.b.a. Smiths Medical Company, 300 Corporate Woods Pkwy, Vernon Hills. Illinois, USA 60061. Model Number: 32-005587", "product_quantity": "96,828 32 oz bottles", "reason_for_recall": "Lack of sterility assurance:  leaking containers which could lead to exposure to infectious agents.", "recall_initiation_date": "20170905", "center_classification_date": "20180105", "termination_date": "20181219", "report_date": "20180117", "code_info": "Lot: A257, EXP 05-20-2018; A258, EXP 05-19-2018; B017, EXP 01-12-2019; B116, B119, EXP 05-03-2019; B120, EXP 05-04-2019; B131, EXP 05-05-2019; Z535, EXP 10-13-2017; Z638, EXP 12-19-2017.", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; MAGNESIUM CHLORIDE, Tablet, 64 mg may be potentially mislabeled as    VITAMIN B COMPLEX W/C, Tablet, NDC 00904026013, Pedigree: AD52993_31, EXP: 5/17/2014;  ASPIRIN EC, Tablet, 325 mg, NDC 00904201360, Pedigree: W003526, EXP: 6/21/2014;  NICOTINE POLACRILEX, LOZENGE, 2 mg, NDC 00135051001, Pedigree: W002766, EXP: 6/6/2014;  THIAMINE HCL, Tablet, 100 mg, NDC 00904054460, Pedig", "address_2": "", "product_quantity": "720 Tablets", "code_info": "MAGNESIUM CHLORIDE, Tablet, 64 mg has the following codes    Pedigree: AD52993_4, EXP: 5/17/2014;  Pedigree: W003527, EXP: 6/21/2014;  Pedigree: W002712, EXP: 6/6/2014;  Pedigree: W003359, EXP: 6/19/2014;  Pedigree: W003923, EXP: 6/28/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MAGNESIUM CHLORIDE, Tablet, 64 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 68585000575", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-733-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76282", "recalling_firm": "Sun Pharmaceutical Industries, Inc.", "address_1": "270 Prospect Plains Rd", "address_2": "N/A", "postal_code": "08512-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0446-2017", "product_description": "buPROPion Hydrochloride Extended-release Tablets, USP (SR), 200 mg, 60 count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India   NDC 47335-0738-86", "product_quantity": "11,618 bottles", "reason_for_recall": "Failed Dissolution Specifications; 18 month stability time point", "recall_initiation_date": "20161220", "center_classification_date": "20170125", "termination_date": "20180711", "report_date": "20170201", "code_info": "JKP0905A 04/17"}, {"status": "Terminated", "city": "Jewett", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "71187", "recalling_firm": "Bee Extremely Amazed LLC", "address_1": "85205 Sportsmans Club Rd", "address_2": "N/A", "postal_code": "43986-9794", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-1142-2016", "product_description": "Jenesis Capsules, 350 mg,  60-count bottles, Manufactured for Timeless Solutions 1810 E. Sahara Ave #100 Las Vegas, Nevada 89104", "product_quantity": "79 bottles", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: tainted product marketed as a dietary supplement. Product found to be tainted with undeclared sibutramine, an appetite suppressant that was withdrawn from the US market for safety reasons, and phenolphthalein, an ingredient found in over-the-counter laxative products that was withdrawn from the US market due to concerns of carcinogenicity, making it an unapproved drug.", "recall_initiation_date": "20151215", "center_classification_date": "20160706", "termination_date": "20200423", "report_date": "20160713", "code_info": "All lots"}, {"status": "Terminated", "city": "Venice", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87828", "recalling_firm": "Scentsational Soaps & Candles Inc", "address_1": "730 Commerce Dr", "address_2": "N/A", "postal_code": "34292-1726", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0681-2021", "product_description": "Goose Creek Hand Sanitizer aloe Red, White & Blue Anti-Bacterial Spray, 3.38 FL. OZ. (100 mL), Goose Creek www.GooseCreekCandle.com, 1498 S. Wallace Wilkinson Blvd., Liberty, KY 42539, UPC 8 14630 02045 7", "product_quantity": "1,512 bottles", "reason_for_recall": "Chemical contamination: product found to be contaminated with methanol (wood alcohol), benzene and acetaldehyde.", "recall_initiation_date": "20210427", "center_classification_date": "20210719", "termination_date": "20221202", "report_date": "20210728", "code_info": "Lot #: 20259", "more_code_info": ""}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-189-2014", "product_description": "Lipotropic 50ml w/o methionine, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "441 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; CINACALCET HCL Tablet, 60 mg may be potentially mislabeled as    RANOLAZINE ER, Tablet, 500 mg, NDC 61958100301, Pedigree: W003741, EXP: 6/26/2014.", "address_2": "", "product_quantity": "60 Tablets", "code_info": "CINACALCET HCL, Tablet, 60 mg has the following code    Pedigree: W003742, EXP: 6/26/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CINACALCET HCL Tablet, 60 mg, Rx only, Distributed by: AidaPak Service, LLC,  NDC 55513007430", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-625-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205710"], "brand_name": ["BUDESONIDE"], "generic_name": ["BUDESONIDE"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-318", "69097-319", "69097-321"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUDESONIDE"], "rxcui": ["252559", "349094", "351109"], "spl_id": ["664e2f07-caa9-41d7-9aa9-0b744c858de8"], "spl_set_id": ["c52c5382-1400-44b9-95be-a30e1cf706da"], "package_ndc": ["69097-318-86", "69097-318-87", "69097-318-32", "69097-318-53", "69097-319-86", "69097-319-87", "69097-319-32", "69097-319-53", "69097-321-86", "69097-321-87", "69097-321-32", "69097-321-53"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["Q3OKS62Q6X"]}, "product_type": "Drugs", "event_id": "97170", "recalling_firm": "Cipla USA, Inc.", "address_1": "10 Independence Blvd", "address_2": "N/A", "postal_code": "07059-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0541-2025", "product_description": "Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by: Cipla Ltd. Indore SEZ, Pithampur, India. Manufactured for: Ciple USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC# 69097-319-86 (pouch), 69097-319-87 (carton)", "product_quantity": "13,680 ampoules", "reason_for_recall": "Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.", "recall_initiation_date": "20250630", "center_classification_date": "20250722", "report_date": "20250730", "code_info": "Batch # 4IA0505, Exp 09/31/2026"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-275-2014", "product_description": "Taper A prefilled syringes, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "61 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}]